Search
for
Sort by
Research 871–900 of 1000+
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
- Multilineage-differentiating stress-enduring cells alleviate atopic dermatitis-associated behaviors in mice
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Therapeutic potential of oral tofacitinib in alopecia areata: a retrospective study
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects – A 16-Week Randomized, Placebo-Controlled Study
- The potential of regulatory T cell-based therapies for alopecia areata
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Intralesional methotrexate in patchy alopecia areata: trichoscopic evaluation and effect on lesional tumour necrosis factor alpha
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Corticosterone enhances the potency of ethanol against hippocampal long-term potentiation via local neurosteroid synthesis
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Frontal fibrosing alopecia in males: A systematic review
- Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study
- Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching